Revolutionary Therapy for patients with Macular Diseases
GlaiveOptix was created by Christopher Shelby, M.D. and Wayne Woods, PhD. to give hope to previously hopeless patients. Imagine the blind will now see.
The GlaiveOptix lens will provide sight to patients with end stage macular diseases utilizing proprietary nanotechnology.
For information about investing please contact us
Copyright © 2022 GlaiveOptix, Inc. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.